Skip to main content
. 2023 Nov 8;20:257. doi: 10.1186/s12985-023-02154-4

Table 1.

Oligonucleotides used in this study

Name Sequence (5′ to 3′) Application
F10 S:D614G F TCTTTATCAGGGTGTTAACTGCAC Mutagenesis PCR
F10 S:D614G R ACAGCAACCTGGTTAGAAGTATTTG Mutagenesis PCR
F9 S:E484Q F CCTTGTAATGGTGTTCAAGGTT Mutagenesis PCR
F9 S:E484A F CCTTGTAATGGTGTTGCAGGTTTTAATTG Mutagenesis PCR
F9 S:E484K F CCTTGTAATGGTGTTAAGGGTTTTAATTG Mutagenesis PCR
F9 S:E484Q/A/K R TGTGCTACCGGCCTG Mutagenesis PCR
F9 S:Q498R/N501Y F GTTTCCGACCCACTTATGGTGTTG Mutagenesis PCR
TAR F10b F CCAACCATACAGAGTAGTAGTAC TAR fragment
TAR F10 R TCATGTTCAGAAATAGGACTTGTTG TAR fragment [50]
TAR F9 F GGAGTCACATTAATTGGAGAAGC TAR fragment [50]
TAR F9 R GCATCAGTAGTGTCAGCAATGTC TAR fragment [50]
sgRNA N F CGATCTCTTGTAGATCTGTTCTC sgRNA N quantification
sgRNA N Prb FAM/ CAG TAA CCA GAA TGG AGA ACG CAG /BHQ sgRNA N quantification
sgRNA N R CAGTATTATTGGGTAAACCTTGG sgRNA N quantification
38F GAAGTCAGACAAATCGCTCCAG RT-PCR amplicon competition assay
38R ACTAGCGCATATACCTGCACC RT-PCR amplicon competition assay